...
search icon
imdx-img

Insight Molecular Diagnostics Inc. Share Price

IMDX
NAQ
$5.32
-$0.07
(-1.3%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Insight Molecular Diagnostics Inc. Analyst Forecast

Insight Molecular Diagnostics Inc. Share Price Chart

Insight Molecular Diagnostics Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$154.61M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
67.27K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.99
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.32 L
$8.51 H
$5.32

About Insight Molecular Diagnostics Inc., Common Stock

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. Insight Molecular Diagnostics Inc. was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Insight Molecular Diagnostics Inc. Stock Returns

Time FrameIMDXSectorS&P500
1-Week Return-7.16%0.72%-1.31%
1-Month Return-13.5%1.27%0.78%
3-Month Return-15.96%3.13%3.46%
6-Month Return99.25%15.81%6.19%
1-Year Return97.04%8.89%11.68%
3-Year Return-32.49%20.79%71.21%
5-Year Return-95.7%35.89%74.81%
10-Year Return-92.81%138.44%256.59%

Insight Molecular Diagnostics Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.22M2.20M958.00K1.50M1.88M[{"date":"2020-12-31","value":55.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.59,"profit":true},{"date":"2023-12-31","value":68.38,"profit":true},{"date":"2024-12-31","value":85.58,"profit":true}]
Cost of Revenue1.85M778.00K976.00K1.09M1.14M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.94,"profit":true},{"date":"2022-12-31","value":52.61,"profit":true},{"date":"2023-12-31","value":58.76,"profit":true},{"date":"2024-12-31","value":61.51,"profit":true}]
Gross Profit(639.00K)1.42M(18.00K)413.00K740.00K[{"date":"2020-12-31","value":-45,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1.27,"profit":false},{"date":"2023-12-31","value":29.08,"profit":true},{"date":"2024-12-31","value":52.11,"profit":true}]
Gross Margin(52.55%)64.60%(1.88%)27.48%39.34%[{"date":"2020-12-31","value":-81.34,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.91,"profit":false},{"date":"2023-12-31","value":42.53,"profit":true},{"date":"2024-12-31","value":60.9,"profit":true}]
Operating Expenses29.07M55.15M17.98M25.55M61.78M[{"date":"2020-12-31","value":47.06,"profit":true},{"date":"2021-12-31","value":89.26,"profit":true},{"date":"2022-12-31","value":29.1,"profit":true},{"date":"2023-12-31","value":41.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(29.71M)(53.73M)(18.00M)(25.14M)(61.04M)[{"date":"2020-12-31","value":-2971100000,"profit":false},{"date":"2021-12-31","value":-5372500000,"profit":false},{"date":"2022-12-31","value":-1799700000,"profit":false},{"date":"2023-12-31","value":-2513600000,"profit":false},{"date":"2024-12-31","value":-6104100000,"profit":false}]
Total Non-Operating Income/Expense-645.00K(698.00K)229.00K294.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-108.22,"profit":false},{"date":"2023-12-31","value":35.5,"profit":true},{"date":"2024-12-31","value":45.58,"profit":true}]
Pre-Tax Income(31.19M)(52.87M)(18.61M)(24.86M)(60.66M)[{"date":"2020-12-31","value":-3118600000,"profit":false},{"date":"2021-12-31","value":-5287100000,"profit":false},{"date":"2022-12-31","value":-1861200000,"profit":false},{"date":"2023-12-31","value":-2485500000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
Income Taxes(1.25M)(9.26M)54.83M--[{"date":"2020-12-31","value":-2.29,"profit":false},{"date":"2021-12-31","value":-16.89,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(43.61M)(73.44M)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4361000000,"profit":false},{"date":"2022-12-31","value":-7344000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(43.61M)(18.61M)(24.86M)(60.66M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4361000000,"profit":false},{"date":"2022-12-31","value":-1861200000,"profit":false},{"date":"2023-12-31","value":-2485500000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(29.93M)(64.10M)(72.90M)(27.78M)(60.66M)[{"date":"2020-12-31","value":-2993200000,"profit":false},{"date":"2021-12-31","value":-6409700000,"profit":false},{"date":"2022-12-31","value":-7290200000,"profit":false},{"date":"2023-12-31","value":-2778100000,"profit":false},{"date":"2024-12-31","value":-6066300000,"profit":false}]
EPS (Diluted)(0.46)(0.71)(0.66)-(6.27)[{"date":"2020-12-31","value":-46,"profit":false},{"date":"2021-12-31","value":-71,"profit":false},{"date":"2022-12-31","value":-66,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-627.16,"profit":false}]

Insight Molecular Diagnostics Inc. Ratios

Insight Molecular Diagnostics Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IMDX
Cash Ratio 2.44
Current Ratio 2.79
Quick Ratio 2.73

Insight Molecular Diagnostics Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMDX
ROA (LTM) -22.17%
ROE (LTM) -428.96%

Insight Molecular Diagnostics Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMDX
Debt Ratio Lower is generally better. Negative is bad. 1.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.21

Insight Molecular Diagnostics Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMDX
Trailing PE NM
Forward PE NM
P/S (TTM) 22.55
P/B 8.00
Price/FCF NM
EV/R 14.11
EV/Ebitda NM

FAQs

What is Insight Molecular Diagnostics Inc. share price today?

Insight Molecular Diagnostics Inc. (IMDX) share price today is $5.32

Can Indians buy Insight Molecular Diagnostics Inc. shares?

Yes, Indians can buy shares of Insight Molecular Diagnostics Inc. (IMDX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Insight Molecular Diagnostics Inc. be purchased?

Yes, you can purchase fractional shares of Insight Molecular Diagnostics Inc. (IMDX) via the Vested app. You can start investing in Insight Molecular Diagnostics Inc. (IMDX) with a minimum investment of $1.

How to invest in Insight Molecular Diagnostics Inc. shares from India?

You can invest in shares of Insight Molecular Diagnostics Inc. (IMDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Insight Molecular Diagnostics Inc. shares
What is Insight Molecular Diagnostics Inc. 52-week high and low stock price?

The 52-week high price of Insight Molecular Diagnostics Inc. (IMDX) is $8.51. The 52-week low price of Insight Molecular Diagnostics Inc. (IMDX) is $2.32.

What is Insight Molecular Diagnostics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Insight Molecular Diagnostics Inc. (IMDX) is

What is Insight Molecular Diagnostics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Insight Molecular Diagnostics Inc. (IMDX) is 8.00

What is Insight Molecular Diagnostics Inc. dividend yield?

The dividend yield of Insight Molecular Diagnostics Inc. (IMDX) is 0.00%

What is the Market Cap of Insight Molecular Diagnostics Inc.?

The market capitalization of Insight Molecular Diagnostics Inc. (IMDX) is $154.61M

What is Insight Molecular Diagnostics Inc.'s stock symbol?

The stock symbol (or ticker) of Insight Molecular Diagnostics Inc. is IMDX

How Can Investors Use Insight Molecular Diagnostics Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Insight Molecular Diagnostics Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Insight Molecular Diagnostics Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Insight Molecular Diagnostics Inc. shares for Indian investors?

When investing in Insight Molecular Diagnostics Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Insight Molecular Diagnostics Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Insight Molecular Diagnostics Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Insight Molecular Diagnostics Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Insight Molecular Diagnostics Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top